Federated Hermes, Inc. Esperion Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$30.04 - $51.31 $387,516 - $661,899	-12,900 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$27.44 - $73.84 $340,887 - $917,314	12,423 Added 2604.4%	12,900 $407,000
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $49,984 - $84,465	-1,412 Reduced 74.75%	477 $28,000
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $24,990 - $34,459	725 Added 62.29%	1,889 $69,000
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $46,676 - $60,912	1,164 New	1,164 $54,000

217

127M

1.61M

1.1M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.